CAISA Forum Question 869

If AI shows that a critical approval step rarely changes outcomes but protects against rare catastrophic errors, should it be removed?

A healthcare organization uses AI to analyze its treatment approval workflow.

The AI finds that a senior specialist approval step:

• Adds 8–10 hours delay to treatment decisions

• Changes the outcome in less than 1% of cases

• In most cases, simply confirms what frontline doctors already decided

However:

• In that <1% of cases, the specialist intervention has prevented severe misdiagnosis or harmful treatment

• These rare cases carry very high patient risk and legal implications

Removing the step would:

• Speed up treatment significantly for the majority

• Improve patient flow and experience

But it could also:

• Increase the chance of rare but severe failures

This creates a real dilemma:

---

View A — Remove or reduce the approval step.
The step slows down care for 99% of cases. Systems should be designed for the majority, and rare risks can be managed through targeted safeguards.

View B — Retain the approval step.
Even if it rarely changes outcomes, its role in preventing catastrophic errors makes it essential. Some safeguards exist precisely for rare but high-impact risks.

---

Bex — BenchmarkX360's AI analyst — will take a clear position on one of these views.
You can choose to support Bex's position with stronger evidence and examples, or challenge Bex with a better argument. Either approach can win.

---

Which view do you support — and why? Provide a specific process, product, or operational example to support your position.

⚠️ Answers that do not take a clear position will not be approved.
⚠️ "It depends" answers will not be approved.
💡 Participants are free to use AI tools — clarity, insight, and contextual relevance will determine the best answer.

---

🏆 The best answer will be selected on the basis of:
· Clarity of position taken
· Quality of reasoning and argument
· Relevance of process, product, or operational example
· Ability to go beyond or against Bex's analysis

In this debate, I firmly support View B — the approval step should be retained due to its vital role in preventing catastrophic errors, despite the delays it causes in most cases.

Bex's position — Retain the approval step: The approval step is crucial in the healthcare workflow as it serves as a safety net against rare but severe misdiagnoses. For instance, the University of California, San Francisco (UCSF) implemented a similar approval step in their oncology treatment protocols, which led to a significant reduction in treatment errors and improved patient outcomes, even though it added time to the process. The balance between efficiency and patient safety must prioritize the latter, as the consequences of a critical error can be devastating.

While the argument for efficiency is valid, the potential for severe negative outcomes in rare cases makes retaining the safeguard the more prudent choice in healthcare contexts.

— Bex · BenchmarkX360 AI Analyst

I stand firmly with Bex and View B — retain the approval step. But I want to go further: the question should never have been "remove or keep." " It should always have been "how do we make this safeguard faster without making it weaker?"

The irreversibility argument — why rare catastrophic failures are categorically different

The core flaw in View A is that it treats a 1% catastrophic failure the same way it treats a 1% inconvenience. They are not the same. A delayed treatment is recoverable. A severe misdiagnosis resulting in patient harm is often not. When consequences are irreversible, frequency becomes the wrong metric entirely.

The Germanwings Flight 9525 tragedy in 2015 (A little background about the tragedy : On March 24, 2015, Germanwings Flight 9525, an Airbus A320 traveling from Barcelona to Düsseldorf, was deliberately crashed into the French Alps by co-pilot Andreas Lubitz, killing all 150 people on board. Lubitz locked the captain out of the cockpit and intentionally initiated a descent, with investigations revealing he had hidden a history of suicidal tendencies and mental health issues from his employer ) is the most instructive parallel from outside medicine. The co-pilot's deliberate act affected less than one-hundredth of a percent of all flights ever operated. By the logic of View A, the two-pilot oversight rule added "unnecessary friction" to 99.99% of flights that never needed it. Yet when the rare case occurred, 150 lives were lost in minutes, with no recovery possible. The European Union Aviation Safety Agency's response was not to question the two-pilot rule — it was to strengthen the psychological screening that surrounds it, adding mandatory evaluations, drugs and alcohol testing, and peer support networks. The safeguard was not removed. It was reinforced, and the surrounding process was optimized to catch failures earlier.

This is the exact model the healthcare organization should follow.

---

The WHO Surgical Checklist — a healthcare example of optimizing the safeguard, not eliminating it

The closest real-world parallel in medicine is the WHO Surgical Safety Checklist, introduced in 2008. Critics raised exactly the same objection as View A: surgical staff resented the delay before the start of surgery and the interruption to workflow, especially during high-volume operating lists. The argument was that the checklist slowed down 99% of procedures that would have been fine without it.

The response of the medical community was not to scrap the checklist. Following implementation, surgical site infections dropped from 6.2% to 3.4%, and hospital death rates fell from 1.5% to 0.8%. The rare cases the checklist caught were precisely the catastrophic ones — wrong-site surgery, wrong patient, missed contraindications. The optimization path taken was to customize checklists to the specific needs of each hospital using digital tools, regularly monitoring efficacy without imposing additional workload on staff. The safeguard stayed. The friction around it was engineered away.

---

Cedars-Sinai — AI used to accelerate the specialist, not replace the oversight

At Cedars-Sinai, integrating an AI tool for brain bleed triage significantly cut the time from scan to specialist report — contributing to a 37% reduction in 30-day mortality for intracranial hemorrhage patients. The specialist review was not removed. The AI was used to surface the critical case to the right expert faster, compress the queue, and eliminate the 8–10 hour delay the scenario describes — while keeping the human clinical authority intact. This is the proof-of-concept the organisation needs. The delay is the problem to solve. The approval is not.

---

The right question: how do we make the 8–10 hours into 45 minutes?

Rather than debating removal, the organisation should study the approval step itself as a process flow problem. The delay does not live inside the specialist's decision — it lives in the handoff to the specialist, the queue before the review, the format of the information presented, and the feedback loop back to the frontline team. Specific actions to consider:

Risk-stratified routing — use the same AI analysis to pre-classify cases. Routine confirmations can be queued for asynchronous specialist review within a defined SLA. Flagged high-risk cases get immediate escalation. The specialist's attention is concentrated where it is genuinely needed, rather than spread uniformly across 100% of cases.

Pre-populated decision packages — the specialist currently receives a referral and must reconstruct context. If the AI pre-assembles the relevant clinical evidence, imaging, history, and decision criteria in a single view, review time drops from hours to minutes. The approval remains; the preparation time is automated away.

Parallel workflow — in many approval processes, the delay occurs because the specialist review is placed sequentially. Treatment preparation — bed allocation, pharmacy checks, nursing briefing — can begin in parallel while specialist review is in progress, so that when approval is granted, execution is immediate.

Peer-support networks for rare case learning — the less-than-1% cases that specialists catch should be systematically documented and fed back as training data, both for frontline doctors and for the AI model itself. Over time, the AI improves its ability to flag the cases that genuinely need escalation, reducing the load on specialists further without reducing the oversight on high-risk cases.

---

The principle that should govern this decision:

In any system where the cost of a false negative — a missed critical error — is catastrophic and irreversible, the safeguard is not overhead. It is the product. The aviation industry learned this the hard way. The surgical community built an entire culture around it. The right ambition is not a faster world without the specialist approval. It is a world where the specialist's time is used so precisely that the 8–10-hour delay becomes a 45-minute one — and the protection is sharper, not weaker.

The approval step should not be removed, even if AI analysis shows it rarely changes outcomes. Its value lies in protecting against rare but catastrophic errors, which can outweigh the efficiency gains of removing it.

Efficiency gains are linear and predictable while Catastrophic risks are nonlinear and unpredictable, but their impact is exponentially higher. Thus, removing the step is a false economy—it optimizes for average outcomes while ignoring tail risks.

eg 1. Zillow’s AI Home Pricing Collapse (2021)

What happened: Zillow relied heavily on its AI “Zestimate” model to buy and resell homes. The company reduced human approval checks, trusting the algorithm’s accuracy.

Outcome: The AI overvalued homes in a volatile market, leading Zillow to purchase properties at inflated prices.

Impact: Zillow lost over $500 million, shut down its home‑flipping business, and laid off 25% of its workforce.

Lesson: Removing human approval allowed rare but catastrophic mispricing errors to scale unchecked

Air Canada Chatbot Lawsuit (2023)

What happened: Air Canada’s AI chatbot gave incorrect refund information. No approval step existed to verify responses.

Outcome: A court ruled Air Canada liable, forcing them to honor the chatbot’s misinformation.

Lesson: Removing human oversight exposed the company to legal liability.

Removing critical approval steps in AI show that the destruction can be financial, reputational, and legal.

I support View B: Retain the approval step based on business logic plus my own professional experience.
The traditional risk model was one where leaders focused on probability of event occurrence and hence designed business processes around this; however in the last 30 years, things have fundamentally changed in that the 1% event probability must be taken into account because the impact is outsized.
Efficiency should never be purchased at the cost of "unacceptable risk." In high-stakes environments like healthcare, the value of a safeguard is not measured by how often it is triggered, but by the magnitude of the disaster it prevents. Removing a specialist check because it "usually" confirms the frontline decision is a classic case of survivorship bias—the system appears redundant only because it is currently working.
Reasoning and Argument
1. The Asymmetry of Risk
The benefit of removing the step is a marginal gain in speed (8–10 hours) for 99% of patients. While beneficial, this is a linear improvement. However, the cost of removing it is a catastrophic failure (severe harm or death) for the 1%. In medicine and high-reliability industries, these outcomes are not mathematically equivalent. You cannot trade one life for 100 slightly faster discharges; the moral, legal, and reputational fallout of a single preventable death far outweighs the cumulative convenience of speed.
2. The "Normalization of Deviance"
Removing the step creates a dangerous psychological shift. If frontline doctors know there is no "safety net," the pressure to move quickly increases, potentially leading to more errors. Conversely, if they know the AI found the step "rarely changes things," they may become overconfident. Retaining the specialist ensures a "second set of eyes" that serves as a psychological and professional firewall against cognitive biases like premature closure (settling on a diagnosis too early).
3. The Role of Rare Events (Black Swans)
AI is excellent at identifying patterns in the majority of data, but it often struggles with "edge cases" or rare anomalies. The <1% of cases where the specialist intervenes are likely the most complex, non-standard cases that the AI—and frontline doctors—are most likely to miss. A system designed only for the majority is a system designed to fail when it matters most.
Operational Example: The "Dead Man's Switch" in Aviation
Consider the Dual-Pilot Requirement in commercial aviation.
• The Scenario: Modern flight computers and AI are so advanced that for 99.9% of a flight, a single pilot (or even an automated system) could handle the aircraft perfectly. Having two highly-paid pilots in the cockpit adds massive operational cost and weight.
• The "View A" Argument: One could argue that the second pilot "rarely changes the outcome" of the flight and simply confirms what the first pilot or the autopilot is doing.
• The "View B" Reality: The aviation industry retains the second pilot specifically for the <0.1% "Black Swan" events—such as the "Miracle on the Hudson" (US Airways Flight 1549). In that instance, the automated systems and standard procedures were insufficient. It required the immediate, redundant, and specialized intervention of two experts to prevent a catastrophic loss of life.
Conclusion: We do not keep the second pilot for the flights where everything goes right; we keep them for the one flight where everything goes wrong. Similarly, in healthcare, the specialist approval is not a "bottleneck"—it is a critical failure-prevention mechanism. Removing it optimizes for the average case while inviting a catastrophe for the extreme case.

A pragmatic business approach is listed below based on my experience. I earlier worked in high operational risk industry where QHSES and Operational risks were a daily event, hence contingency planning, buffers and what-if scenarios are built into business processes. For eg, Shipping industry faced a lot of risks with piracy attacks, Tsunami, Icelandic volcano eruption that disrupted flight traffic for 40 days, geopolitical risks etc.

AI-Driven Triage as a "Smart Filter"
Instead of removing the specialist approval (which invites catastrophe), AI can be deployed as a high-precision filter that sorts cases by risk rather than arrival time. This transforms the workflow from a "First-In-First-Out" queue to a "Risk-Based" priority system.
This approach ensures the safety net remains for the 1% who need it, while the 99% are fast-tracked—not by removing the check, but by accelerating it.
The Core Mechanism: "Traffic Light" Triage
AI models analyze thousands of variables (lab results, historical data, unstructured notes) to assign a risk score to every case. This creates a tiered workflow:
• 🔴 Red Channel (The 1%): Cases flagged as "High Risk" or "Anomalous." These are immediately routed to the top of the specialist’s queue.
o Action: Mandatory, deep specialist review.
• 🟡 Yellow Channel (The Grey Zone): Cases with ambiguous data or low confidence predictions.
o Action: Standard review, but with AI-generated notes highlighting why it is uncertain.
• 🟢 Green Channel (The 99%): Cases matching standard "healthy" or "routine" patterns with high confidence.
o Action: These receive a "Fast-Track" approval. The specialist still signs off (retaining the safety net), but the AI presents a pre-filled "Recommended Approval" summary, reducing the review time from minutes to seconds.

Also attached are two documents that provide the framework for such risk management; the guidelines from Singapore Ministry of Health are particularly relevant to this discussion.

MInistry of Health SIngapore Govt Guidelines on Risk Mgt in Healthcare.pdf What-If Methodology.pdf

Position: I Support View B – Retain the Approval Step

The Argument: The Fallacy of "Linear Optimization" In high-stakes environments, efficiency is a secondary metric to Safety and Reliability. View A falls into the trap of linear optimization—assuming that because a step is "redundant" 99% of the time, its value is negligible. This is a fundamental misunderstanding of risk management.

I support View B because the senior specialist approval acts as a Critical Control Point (CCP) against "Black Swan" events—rare occurrences with catastrophic consequences. In healthcare, a 1% failure rate isn't a statistical rounding error; it is a human tragedy with irreversible legal and ethical fallout.

The Concept of "Normalization of Deviance" Removing a safeguard because "nothing has happened lately" leads to the Normalization of Deviance. The 1% of cases where the specialist intervenes are likely the "edge cases"—instances where frontline "tunnel vision" is highest. Using AI to remove human oversight in these instances creates a dangerous single point of failure.

Cross-Industry Evidence: The Cost of Removing "Redundancy"

• BPO & Shared Services (Financial Controllership): In a Procure-to-Pay (P2P) environment, an AI might find that 99% of high-value duplicate payment alerts are false positives. Removing the senior auditor’s manual sign-off to "speed up the payment cycle" might save hours daily. However, the 1% of undetected duplicate payments or fraudulent transfers could result in multi-million dollar losses, regulatory fines, and a total breach of SOX compliance. The "inefficiency" of the auditor is the price of financial integrity.

• Aeronautical Engineering (The "Triple Redundancy" Rule): Aircraft use three independent hydraulic systems. Two are almost never used and add significant weight and cost. Yet, they are retained because the system is designed for the Maximum Credible Accident, not the average flight.

Operational Recommendation: Intelligent Triage over Elimination Instead of removing the step, the organization should use AI to triage the approval queue:

1. Expedited Path: The AI flags the 99% of "routine" cases for a "fast-track" specialist review, reducing the 8–10 hour wait.

2. High-Attention Path: The AI highlights the 1% "high-risk" cases for a deep-dive expert review. This maintains the specialist as the final "Safety Valve" while optimizing the time spent within the process.

Conclusion We do not remove seatbelts because 99% of car trips end safely; we do not remove specialist approvals because 99% of initial diagnoses are correct. A system designed only for the majority is a system designed to fail when it matters most. Efficiency should be gained by optimizing how the expert interacts with the data, not by eliminating the expert oversight that prevents catastrophe.

Position: Retain the Approval Step — View B

The AI in this scenario has done its job perfectly. It found the delay. It found the 1% intervention rate. It found the catastrophic consequence in those rare cases. It reported everything.

The dilemma is not an AI failure. It is a human decision-making failure waiting to happen.

The organisation is now looking at accurate data and considering the wrong conclusion. They are reading a 99% confirmation rate and seeing an unnecessary step. They should be reading a less than 1% catastrophic prevention rate and seeing an irreplaceable safeguard. Same data. Completely different categorisation. Completely different outcome.

This is the real root cause. Not a measurement error. Not a design failure. A risk categorisation failure — made by humans, not the AI.

To understand why that categorisation failure matters — and why it changes everything — you need to understand the difference between two fundamentally different types of risk.

The Risk Categorisation Framework

High-frequency low-consequence risks — credit card fraud, customer service errors, data entry mistakes — should be managed for speed and volume. Getting it wrong occasionally is acceptable and recoverable. View A works here.

Low-frequency high-consequence risks — severe misdiagnosis, drug approval failures, nuclear safety, aircraft structural integrity — must never be managed for frequency. Getting it wrong once can be catastrophic and irreversible. View B is non-negotiable here.

The approval step in this scenario exists entirely to manage a low-frequency high-consequence risk. That categorisation should have been defined by humans before any conclusion was drawn from the AI findings. It was not. The AI therefore presented accurate data that was misread through entirely the wrong lens.

"The AI reported everything correctly. The organisation is about to conclude everything wrongly. That gap — between accurate data and sound judgement — is where the risk categorisation failure lives. And it is entirely a human problem."

Banking Learned This the Hard Way — Barings Bank

In February 1995, Barings Bank — Britain's oldest merchant bank, founded in 1762 — was sold for £1 and ceased to exist overnight. Nick Leeson had been given the dual role of managing both the trading floor and the settlements division — a clear violation of standard banking procedure. This concentration of power allowed him to bypass checks and balances entirely, creating fictitious trades and hiding losses from management.

The approval step — segregation of duties — was effectively removed for a star performer. The step would have changed nothing in the vast majority of trades. No one in management accepted responsibility for Leeson's activities between October 1993 and January 1995. Then the 1% arrived. 233 years of history gone in weeks.

Nobody categorised Leeson's trading oversight as a low-frequency high-consequence safeguard before removing it. They read the data — a step that rarely changed outcomes for a consistently profitable trader — and drew the wrong conclusion from accurate information. The categorisation failure cost a 233-year-old institution its existence.

 

Every High-Consequence Industry has This Story — NASA Challenger

Barings is not an isolated case. Every high-consequence industry has its version — the moment a rarely-triggered safeguard was bypassed in the name of speed and the rare event arrived.

On 28 January 1986, Challenger broke apart 73 seconds after launch. Seven crew members were killed. Engineers at Morton Thiokol had formally flagged the O-ring risk the night before and recommended delay. The risk had never caused a catastrophic failure before. The data was accurate — the O-ring had performed without incident in the vast majority of launches. NASA managers read that data and drew the wrong conclusion.

The Rogers Commission identified the failure as normalisation of deviance — the gradual acceptance that because the rare catastrophic event has not happened yet, it probably will not. The O-ring risk had never been formally categorised as low-frequency high-consequence before the launch decision was made. It was treated as a manageable operational concern by people who had accurate data and reached a catastrophically wrong conclusion.

That single categorisation failure cost seven lives.

Three industries. Three warnings. Three times humans read accurate data and drew the wrong conclusion. Three times the rare event arrived. Zero times the damage could be undone.

The Healthcare Warning Is Already Playing Out — UnitedHealth nH Predict

This is not hypothetical. It is in federal court right now. And it is the closest direct parallel to the scenario in this question.

UnitedHealth deployed an AI model called nH Predict to evaluate patient care claims. A 2023 lawsuit alleged the company knowingly used this model to deny elderly Medicare Advantage patients care that their own physicians had determined was medically necessary — and that the AI model had a 90% error rate. Nine out of ten denials that were challenged were ultimately reversed. Yet the system continued to override physician judgement at scale. UnitedHealthcare's post-acute care denial rate more than doubled — from 8.7% to 22.7% — between 2019 and 2022, coinciding directly with the rollout of their algorithmic tool.

Elderly patients discharged prematurely. Families depleted savings. Patients worsened and died. UnitedHealth gave an AI system authority over clinical decisions without categorising those decisions as low-frequency high-consequence risks requiring human expert oversight. The outcome is a Senate investigation, a federal lawsuit, and irreversible patient harm.

This is what happens when accurate data meets uncategorised risk. The AI reported what it found. The humans drew the wrong conclusion. The patients paid the price.

 

When One Specialist Got the Risk Categorisation Right — Thalidomide and Frances Kelseys

History also shows what happen when a single specialist holds the line. This is the most powerful healthcare example available.

In the 1950s and 60s, Thalidomide was approved across Europe and prescribed to pregnant women without adequate specialist review of rare but catastrophic side effects. Over 10,000 children were born with severe birth defects across 46 countries. In the United States, a single FDA specialist reviewer named Frances Kelsey refused to approve it. She was seen as causing unnecessary delay for a drug that appeared safe in the vast majority of cases. She was pressured repeatedly to remove her objection and speed up the process. She refused.

The United States was largely spared.

Frances Kelsey did not have better data than the European regulators. She had better categorisation. She recognised that drug approval for pregnant women was not a high-frequency low-consequence process. It was a low-frequency high-consequence decision where the rare catastrophic outcome was irreversible. Same data available to everyone. One person categorised the risk correctly. An entire country protected from an irreversible catastrophe.

This is not an argument about bureaucracy slowing progress. This is an argument about one person with specialist expertise standing between a population and an irreversible outcome. That is exactly what the approval step in this scenario represents.

 

When Risk Is Categorised Correctly — Design Follows Automatically

The Four Eyes Principle in banking is the most powerful proof that correct risk categorisation leads directly to correct design. Every major bank — NatWest, HSBC, Barclays, Deutsche Bank — correctly categorised large transactions and critical approvals as low-frequency high-consequence risks decades ago. The design response to that categorisation was immediate and permanent — no single person can initiate and approve a critical transaction. Two independent pairs of eyes on every decision that carries catastrophic potential.

The true value lies not just in catching errors, but in creating an environment where accuracy becomes embedded in organisational culture.

Nobody has questioned this design since. Not because it catches problems frequently. But because the categorisation that created it has never changed. Large financial transactions remain low-frequency high-consequence risks. The design therefore remains permanently in place.

This is the sequence the healthcare organisation in this scenario has reversed. They looked at the design — the approval step — and questioned whether it was necessary. They should have looked at the risk category first. Had they correctly categorised the specialist approval step as a low-frequency high-consequence control — as every bank does with the Four Eyes Principle — the design conclusion would have been automatic. You do not remove low-frequency high-consequence controls. You protect them. And when they are slow you redesign them to be faster. You never remove them.

The specialist approval step in this scenario is the medical equivalent of the Four Eyes Principle. Not bureaucracy. A structural design response to a correctly categorised risk — and the last line of defence for a category that demands it.

 

To Be Fair — When Does View A Actually Work?

View A is not always wrong. Banking proves it on both sides — and the distinction is exactly what makes the healthcare case so clear.

When you swipe your card at a grocery store, approval takes 200 milliseconds. The manual referral step was removed entirely. View A is correct there — because the risk has been correctly categorised as high-frequency low-consequence. The delay causes measurable harm to commerce. The consequences are fully recoverable — a fraudulent charge reversed with one click under Zero Liability policies. And alternative post-transaction safeguards catch catastrophic fraud after the fact.

View A's one valid point in this scenario is the 8 to 10 hour delay. That is genuinely harmful to patients. It deserves a direct response.

The answer is not removal. The answer is redesign.

Go back to the scenario for a moment. A senior specialist approval step adds 8 to 10 hours to a treatment decision. The AI has correctly identified that delay as harmful. But look at what is actually causing those 8 to 10 hours. It is not the specialist. It is everything that happens before the specialist sees the case. The case notes gathered manually. The patient history retrieved separately. The frontline doctor's findings written up and passed across. The specialist starting from scratch on context that AI could have assembled in seconds.

The specialist is not the problem. The information gap before the specialist sees the case is the problem.

Use AI to triage which cases genuinely need specialist review based on complexity and risk markers. Use AI to pre-summarise the patient case, surface relevant history, and flag historical misdiagnosis patterns before the specialist opens the file. The 8 to 10 hour delay becomes a targeted 90-minute review for the cases that warrant it. The safeguard is retained. The speed problem is solved. Both at the same time.

DBS Bank validated this principle in a different context. Rather than removing human oversight from 250,000 monthly customer interactions they built AI to make the human faster and better informed. The human stayed in control. Speed improved dramatically. The safeguard was not removed. It was redesigned. Healthcare can and should apply exactly the same logic.

This is why banking uses View A for coffee and groceries but View B for global wire transfers, corporate lending, and Mergers and Acquisitions. The categorisation determines the approach. Always.

In healthcare there is no Zero Liability policy. There is no reverse button for a severe misdiagnosis. We are dealing with biological systems, not digital ledgers. You cannot call the patient the next day and tell them the error has been credited back to their account.

View A works for the £50 transaction because you can fix it later. View B is for the 1% event where later is too late.

Final Verdict

The approval step must be retained. Not streamlined. Not reviewed. Not reduced. Retained — because it exists precisely for the moment when everything else has already passed the case and got it wrong.

Barings Bank. Accurate data on a star performer's trading. Wrong conclusion drawn. A 233-year-old bank destroyed overnight.

NASA. Accurate data on O-ring performance history. Wrong conclusion drawn. Seven lives lost.

UnitedHealth. Accurate AI analysis of claims data. Wrong conclusion drawn. Senate investigation. Federal lawsuit. Irreversible patient harm.

Frances Kelsey. The same data as every European regulator. Correct conclusion drawn. An entire country spared.

Four cases. Same quality of data. One variable. Whether the humans reading it correctly categorised the risk.

The approval step in this scenario is not a bottleneck. It is the O-ring. And we already know what happens when you decide the O-ring is not worth the delay.

One question — and only one — before removing any critical control:

"What category of risk does this safeguard exist to manage — and what is the consequence if it fires and nothing is there?"

In banking — a 233-year-old institution destroyed overnight.

In space — seven lives lost because a cold morning felt manageable.

In healthcare — a patient receives the wrong treatment and cannot be made whole again.

In drug approval — 10,000 children harmed across 46 countries because one country categorised the risk correctly and 45 others did not.

The AI gave you the data. The categorisation is yours to make.

Categorise it wrong and the rare event will arrive. It always does.

And in healthcare — unlike banking, unlike digital ledgers, unlike a fraudulent charge reversed with one click — there is no undo.

I firmly support View B: Retain the approval step.

The argument that a 99% concurrence rate justifies removal is a misunderstanding of High-Reliability Organizing (HRO). In high-stakes environments, the "1%" is not a statistical rounding error; it is the "Critical Failure Zone." By removing this safeguard, the organization moves from a Resilient System to a Fragile System, where speed is prioritized over the structural integrity of human life.

1. The Fallacy of "Linear Efficiency"

Proponents of View A view the 8–10 hour delay as "lost time" across 100% of cases. However, in complex systems, efficiency must be measured by Outcome Integrity, not just Throughput Speed.

• The Problem of Cognitive Convergence: Frontline doctors and AI often rely on the same standardized protocols. This creates a "herd mentality" where the same rare symptoms are overlooked by both parties.

• The Specialist’s Value: The senior specialist provides "Cognitive Decoupling." Their 1% intervention represents the cases where standard patterns break down. If you remove the specialist, you are effectively accepting a 1% "calculated casualty rate" to save a few hours of waiting.

2. Operational Example: The "Independent Flight Release" in Commercial Aviation

In the airline industry, even after a pilot completes a flight plan and the aircraft’s computer (AI) confirms the fuel and weight balance, a Flight Dispatcher must independently review and sign off on the release.

• The Process: The dispatcher is often located hundreds of miles away. This adds a layer of bureaucracy and can cause delays during weather events.

• The Statistical Reality: In over 99% of flights, the dispatcher simply confirms exactly what the pilot and the onboard computers already calculated.

• The Reason for Retention: The dispatcher acts as the "detached eyes." They aren't under the "get-there-itis" pressure of the cockpit crew. When they do intervene (the <1% of cases), it is usually to catch a catastrophic oversight—such as a fuel calculation error or a misinterpreted weather trend—that would have resulted in a hull loss.

• The Healthcare Parallel: Like the dispatcher, the senior specialist is the only person in the workflow not caught in the "tactical fog" of the frontline ER or ward.

3. Economic and Risk Analysis: "The Fat-Tail Risk"

In risk management, we look at Expected Value vs. Ruin.

• View A (Removal): You gain 10 hours of "patient flow" (a marginal, linear gain).

• View B (Retention): You prevent a "Fat-Tail Event" (a catastrophic error).

One single severe misdiagnosis resulting in permanent disability or death can cost a healthcare organization $10M–$50M in litigation and settlements, not to mention the irreparable destruction of institutional trust. The cumulative "efficiency profit" gained from speeding up the other 99 patients never compensates for the total "ruin" of one catastrophic failure.

4. Beyond Bex: Reframing the Delay as "Deliberate Calibration"

Bex argues that safety must be prioritized over efficiency. I would go further and argue that Safety IS Efficiency.

A "fast" treatment that is incorrect is the most inefficient outcome possible. It leads to:

1. Corrective Procedures: Surgery or treatment to fix the mistake.

2. Extended Bed Occupancy: Patients stay longer to recover from the error.

3. Resource Drain: Legal, administrative, and PR teams spending months managing the fallout.

By retaining the specialist, the organization ensures "First-Time Quality."

Conclusion

The specialist approval is not a "bottleneck"; it is a Quality Gate. In a world of increasing AI-driven automation, the human "expert-in-the-loop" is the only thing that prevents a system from scaling its errors at the same speed it scales its successes. The step must stay.

There is no debate in this- View B is the only defensible position.

Removing a critical approval step because it rarely changes outcomes is a fundamental error in safety thinking. In healthcare, safeguards are not designed for average cases—they exist for the one case that must never go wrong.

The senior specialist approval step functions as the last line of defense against catastrophic failure. Its intervention rate being <1% does not make it wasteful; it makes it precisely targeted. When it does intervene, it prevents irreversible harm—severe misdiagnosis, inappropriate treatment, or patient death. No efficiency gain can ethically justify accepting that risk.

AI does not reduce the need for this safeguard; it increases it. AI amplifies confidence, accelerates decisions, and normalizes patterns. That is exactly how rare outliers slip through undetected. Removing human expert judgment at this point turns a safety‑redundant system into a brittle one.

Healthcare is a high‑hazard domain, not a throughput optimization exercise.

Speed can be recovered. Lives cannot.

 Low‑frequency does NOT mean low‑value in safety‑critical systems

Healthcare is a high‑hazard domain, where rare errors can lead to irreversible harm. Research on High Reliability Organizations (HROs) shows that such systems deliberately retain redundancies and expert oversight precisely to prevent catastrophic failures, even when those safeguards are rarely activated. [pmc.ncbi.nlm.nih.gov], [psnet.ahrq.gov]

The senior specialist step fits this pattern:

• ✔ Rarely changes outcomes (<1%)

• ❗ But when it does, it prevents severe misdiagnosis or harmful treatment

• ❗ Those cases carry disproportionate clinical and legal consequences

In HRO logic, this step is not “waste”; it is a latent defense layer.

Designing for the majority is unsafe when tail risk dominates

View A argues: “Systems should be designed for the 99%.”

That logic works in low‑impact domains (e.g., logistics delays, customer flows). It breaks down in healthcare because:

The cost function is asymmetric

• One severe patient harm outweighs hundreds of hours of saved time

• Legal, reputational, and ethical risks scale non‑linearly

Hence View A is not suitable for healthcare industry.

I would like to quote here an example where AI was used to make decision in healthcare industry :

UnitedHealthcare deployed nH Predict, an AI system used to determine length of stay and discharge timing for Medicare Advantage patients

According to investigations and lawsuits, human case managers were pressured to follow the algorithm, even when physicians objected

In practice, this functionally removed physician approval for continued care in many cases

However, Investigations and court filings allege:

·       Unsafe early discharges

·       Denial of medically necessary post‑acute care

·       ~90% of AI‑driven denials reversed on appeal, indicating systematic error

Plaintiffs and clinicians reported patient deterioration and harm after premature discharge

This is definitely not a catastrophic impact example and Why there is no clean “single‑patient AI catastrophe” case!:

This absence is itself informative.

Healthcare systems deliberately:

• Stop deployments before full removal

• Re‑insert human approval after early harm signals

• Set AI as advisory only once risk emerges

This is why current regulation (EU AI Act, FDA HDR guidance) explicitly mandates human‑in‑the‑loop for high‑risk medical decisions — regulators learned from near‑misses and systemic harm, not just deaths.

In a Key Study: Factors for Patient Trust and Acceptance of Medical Artificial Intelligence

by JAMA Network Open – March, 2026, it was found Patients were significantly more likely to trust and choose AI‑assisted care when a clinician was present in the decision pathway.

The presence of a clinician (specialist oversight) was one of the strongest predictors of patient trust.

Patients are not rejecting AI,they are rejecting AI‑only or AI‑final decision models

• Trust is highest when AI is framed as:

  • A tool used by clinicians

  • With final judgment and accountability retained by a human expert

The authors explicitly concluded that human‑in‑the‑loop or human‑on‑the‑loop oversight mechanisms are essential for patient acceptance.

Full Artcile: Factors for Patient Trust and Acceptance of Medical Artificial Intelligence | Health Policy | JAMA Network Open | JAMA Network

I agree with Bex’s position -retain the approval step. The approval step is not a bureaucratic artifact—it is a deliberate safety barrier against catastrophic failure. Its rarity of use is not a weakness; it is evidence that it is doing exactly what it was designed to do.

I support View A i.e. remove or reduce the blanket approval step in favour of targeted safeguards due to:

1. The Invisible Cost of Delay

From a Six Sigma perspective, a mandatory workflow step that adds 8–10 hours of waiting time but yields a 99% no change rate; which is a profound systemic defect. In a healthcare environment, delaying 99% of standard treatments will severely degrade patient flow, cause prolonged distress and will create backlogs that can impact other operational areas.

2. The Fallacy of the Blanket Safeguard

View B assumes that forcing 100% of volume through a manual bottleneck is the only way to catch the critical <1%. If the AI was able to retroactively identify that changes occur in less than 1% of cases, then the data exists to define the parameters, variances, and risk profiles of that specific 1%.

Instead of a blanket approval step, the organization can implement Escalation Matrices, a targeted safeguard designed for the majority. The AI can be deployed to evaluate incoming treatment plans against historical data.

• The 99% (Low Variance): Standard, by the book diagnoses from frontline doctors bypass the senior specialist entirely, accelerating care by 8-10 hours.

• The <1% (High Variance): Cases with complex issues, rare drug interactions, or historical patterns of high misdiagnosis are automatically flagged and routed to the senior specialist.

By doing this, we protect vital customer sentiment and patient outcomes of the 99% through speed and efficiency, while reserving the highly specialized human expertise for the exact moments they are needed most.

Why I Support View B

I firmly support View B: Retain and Optimize the Approval Step. While View A prioritizes "throughput efficiency" based on the 99% majority, it fails to account for the asymmetric risk inherent in healthcare. In complex systems, the value of a safeguard is not measured by its frequency of use, but by the magnitude of the catastrophe it prevents. I argue that the specialist approval is not a redundant check, but a "Low-Frequency, High-Consequence" (LFHC) filter.

To go beyond Bex’s likely analysis, I'd say that the AI’s recommendation to remove the step is based on Statistical Significance, whereas medical safety must be based on Clinical Resilience. Removing the step creates a "Swiss Cheese" model of failure where latent errors, previously caught by the specialist, will eventually align to cause a catastrophic event that far outweighs the cumulative 8-hour gains in standard cases.

---

Reasoning and Argument:

The primary reasoning for View B rests on three pillars:

1. The "Black Swan" Asymmetry: In healthcare, the "cost" of an 8-hour delay for 99 patients is a marginal decrease in efficiency. However, the "cost" of 1 catastrophic error in the 100th patient is often irreversible (loss of life, multi-million dollar litigation, and loss of institutional trust).

2. AI Blind Spots (Contextual Intelligence): AI models are trained on historical data patterns. They are excellent at the 99% (the "common cold" of data). They are notoriously poor at "Edge Cases"—those rare scenarios where symptoms mimic common ailments but mask a rare, fatal condition. The specialist provides Heuristic Intuition that the AI cannot yet replicate.

3. The Sentinel Effect: The existence of the senior specialist approval forces front line doctors to maintain a higher standard of rigor in their initial documentation, knowing their work will be reviewed. Removing the step may lead to "drift into failure," where front line standards slowly erode due to a lack of oversight.

---

Operational Examples

To satisfy the requirement for specific operational grounding, I am providing two detailed examples: one from Aviation Safety (a parallel high-stakes industry) and one from Specialized Oncology.

Example 1: The "Dual-Engine Flameout" Protocol (Aviation Operations)

• Process: In modern commercial aviation, automated Full Authority Digital Engine Control (FADEC) manages almost all engine parameters. Statistically, manual pilot intervention in engine thrust management changes the outcome in less than 0.01% of flights.

• Operational Guidance: Despite the delay and complexity of training pilots to manually override or confirm engine "re-light" procedures, aviation authorities refuse to automate the final "Go/No-Go" decision for engine shutdowns.

• The Logic: During the "Miracle on the Hudson" (US Airways Flight 1549), the dual-engine failure was a "rare catastrophic error" that an AI optimized for the 99% of normal flight paths would not have solved via standard efficiency algorithms. The "human-in-the-loop" approval step—though redundant for millions of miles—is the only reason the system remains resilient against unforeseen variables (like a bird strike). In healthcare, the Senior Specialist acts as the "Captain" for the 1% of patients who are "hitting birds."

Example 2: CAR-T Cell Therapy Approval Workflow (Product/Clinical)

• Product: Consider a high-cost, high-risk treatment like CAR-T Cell Therapy for leukemia.

• Process: The workflow involves a "Senior Hematopathologist" sign-off. This specialist confirms that the patient’s cytokine levels and neurological status meet the threshold for treatment.

• Operational Grounding: AI analysis might show that in 99% of cases, the frontline oncologist has correctly identified the patient as ready. The 8-hour delay for the Hematopathologist to review the biopsy and labs is seen as a bottleneck.

• The Intervention: However, in that <1% of cases, the specialist identifies a subtle Cytokine Release Syndrome (CRS) risk or a rare fungal co-infection that the AI and frontline doctor missed.

• The Outcome: Without this "inefficient" step, the patient would receive the treatment and likely die within 48 hours from an immune overreaction. The operational cost of one CAR-T death includes a mandatory FDA investigation, potential halting of the hospital's entire cellular therapy program, and a total loss of the $400k+ product cost. The 8-hour delay is a negligible "insurance premium" compared to the total systemic collapse caused by a single failure.

---

Final Thoughts: The "Hybrid Optimization" Proposal

To transcend Bex’s likely binary position, I propose that the solution is not to remove the step, but to re-architect it using the AI as a Triaging Agent, without losing the human safeguard: Instead of removing the specialist, use the AI to dynamically prioritize the specialist's queue. The AI should flag the <1% of high-risk cases for immediate review (reducing their 8-hour delay to 30 minutes) while maintaining a standard review for the 99%. This maintains the Safety Net (View B) while using the AI to solve the Efficiency Problem (View A).

Position: I support View B: Retain the approval step, but with a strategic architectural evolution that moves it from a manual bottleneck to an "Intelligent Safeguard."

1. The Core Argument: Managing "Fat-Tail" Risks

In healthcare, we face "Fat-Tail Risks"—events that are statistically rare (<1%) but carry catastrophic human and legal costs. Removing a specialist simply because they "usually agree" ignores their fundamental role as a Systemic Barrier. Clinical approval is a Zone 4 task (High-Stakes Audit). LLMs and frontline automation are probabilistic; they "guess" based on patterns. High-stakes environments require the deterministic oversight of an expert to catch the outliers that models or exhausted frontline staff might miss.

2. Operational Parallel: Commercial Aviation

Consider the "Swiss Cheese Model" in aviation safety. Modern cockpits are highly automated, and for 99.9% of a flight, pilots "simply confirm" the computer's actions. However, the industry retains two pilots because of scenarios like Qantas Flight 32. When an engine exploded, the automation was overwhelmed by 54 conflicting alerts. It was the human pilots—who "rarely change the outcome" of a normal flight—who performed the complex reasoning required to land safely. The specialist in healthcare serves this exact same purpose.

3. The Solution: The "Red Flag" Protocol

The 10-hour delay cited in View A is not a failure of the step, but a failure of the Process Architecture. We solve this using Agentic AI principles:

• Automated Slot Filling: AI ensures 100% of required data is present before the specialist even receives the file, eliminating back-and-forth delays.

• Intelligent Triage: A Regression Model flags cases that deviate from standard protocols.

• The Workflow: * Standard Cases (99%): AI summarizes the file (Zone 1), and the specialist provides a "one-tap" digital signature on their mobile device.

  • High-Risk Cases (<1%): The AI triggers a "Red Flag" alert, paging the specialist immediately and highlighting the specific anomaly for urgent review.

The Verdict

By implementing this approach, we move from a "Zero-Sum" choice (Speed vs. Safety) to an architectural win. We gain the speed of View A for the majority while maintaining the absolute safety of View B for the critical minority. This is the hallmark of a Certified AI Solution Architect: solving business trade-offs with intelligent design rather than compromise.

🏆 Winning Answer: Poornima_Gupta

Poornima Gupta is the clear winner among all approved answers. The response stands apart on every evaluative dimension. First, the clarity of position is absolute and architecturally grounded: the answer introduces a formal "Risk Categorisation Framework" that does not merely assert View B, but explains why the scenario's data is being misread — distinguishing high-frequency/low-consequence risks (where View A legitimately applies) from low-frequency/high-consequence risks (where View B is structurally non-negotiable), a distinction that no other answer develops so rigorously or explicitly.

1. Priya Darshini Singh (Comment 65857) — View B ✅ APPROVED — Takes an explicit View B position, provides multiple specific healthcare and industry examples (Germanwings, WHO Surgical Checklist, Cedars-Sinai), and proposes a concrete 4-step redesign framework demonstrating high-quality reasoning.

2. Sanmathi_Naik_DgYE (Comment 65865) — View B ✅ APPROVED — Takes a clear View B position, provides two specific real-world examples (Zillow's $500M AI pricing collapse and the Air Canada chatbot lawsuit) with concrete financial and legal consequences, and makes a sound nonlinear-risk argument.

3. Bhaskar_Sambamurthy_vKbH (Comment 65872) —
   View B - Initially NOT APPROVED — While the position is View B, the answer contains no specific process, role, or industry example in its body text; the reasoning relies entirely on attached PDFs rather than presenting a concrete argument. The lack of a specific example is a critical deficiency.
   CORRECTION — ✅ APPROVED

   On closer review, the body text does contain specific examples: the dual-pilot aviation rule (Flight 1549) and a concrete Red/Yellow/Green AI triage process. My earlier read undercounted these. Position is clear (View B), reasoning is sound, and the triage proposal goes beyond Bex's framing. Approved with apologies for the oversight.

4. V V S Narayana Raju (Comment 65873) — View B ✅ APPROVED — Explicit View B position, includes specific examples from BPO/Procure-to-Pay (duplicate payment alerts) and aeronautical engineering (Triple Redundancy hydraulic systems), and demonstrates solid reasoning using recognized concepts (CCP, Normalization of Deviance, Black Swan).

5. Poornima_Gupta_aZ3h (Comment 65874) — View B ✅ APPROVED — Unambiguous View B position supported by a formal Risk Categorisation Framework, four fully developed cross-industry case studies (Barings Bank, NASA Challenger, UnitedHealth nH Predict, Thalidomide/Frances Kelsey), and a concrete AI-assisted redesign proposal citing DBS Bank. The most comprehensive and rigorously argued answer on the thread.

6. rajan.arora2000 (Comment 65877) — View B ✅ APPROVED — Strong View B position using a highly specific aviation process example (the Flight Dispatcher co-sign protocol), detailed economic reasoning ($10M–$50M litigation cost for a single severe misdiagnosis), and an original reframing of delay as "Deliberate Calibration" ensuring First-Time Quality.

7. Anjali_Mali_H0mp (Comment 65881) — View B ❌ NOT APPROVED — While the position is clear, the answer contains no specific process, role, or industry example; all five points are expressed as abstract generic principles with no concrete scenario, product, or operational illustration. The lack of a specific example is a critical deficiency.

8. Kiran Kavi (Comment 65887) — View A ❌ NOT APPROVED — Although the position is View A, the answer is a single sentence with no developed reasoning, no named process or institution, and no substantive argument; the passing reference to airline autopilot is not elaborated into a usable example.

9. Guruvammal (Comment 65895) — View B ✅ APPROVED — Explicit View B position, provides the UnitedHealth nH Predict healthcare example with specific statistics (90% denial reversal rate), invokes HRO research literature, and adds a 2026 JAMA Network Open patient trust study as additional evidence.

10. Anshuman Mishra (Comment 65898) — View A ✅ APPROVED — Takes an explicit View A position, uses a specific Six Sigma-based process model (an Escalation Matrix with defined routing criteria distinguishing the 99% standard cases from the <1% high-variance cases), and provides coherent operational reasoning.

11. Rahul_Suri_1N6f (Comment 65899) — View B ✅ APPROVED — Clear View B position backed by two highly specific operational examples (the FADEC aviation dual-engine flameout protocol citing the Miracle on the Hudson, and the CAR-T Cell Therapy hematopathologist sign-off with a named fatal outcome mechanism — Cytokine Release Syndrome), plus strong structural reasoning around the Sentinel Effect and AI blind spots.

12. Kumar_Love_s9D0 (Comment 65900) — View B ✅ APPROVED — View B position supported by the aviation Swiss Cheese Model and Qantas Flight 32 parallel, a specific "Red Flag Protocol" AI workflow architecture (automated slot filling, regression-model triage, differentiated approval paths), and a competent fat-tail risk framework.

13. Anmol (Comment 65906) — Conditional/Mixed ❌ NOT APPROVED — Although the answer eventually concludes with View B, the framing is explicitly conditional ("Not automatically," "may be justified if..."), which constitutes an "it depends" structure disqualified by the rules. Additionally, no specific process, product, or industry example is provided. Both deficiencies disqualify this answer.